Sodium Thiosulfate for Refractory Metabolic Alkalosis From Diuretic Therapy: A Case Series of Six Patients - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Sodium Thiosulfate as a Treatment for Persistent Metabolic Alkalosis Induced by Diuretics: A Case Series Involving Six Patients

  • September 1, 2026

Share

  • 1

    Sodium thiosulfate (STS) was used in six patients with diuretic-induced metabolic alkalosis after standard treatments failed.

  • 2

    All patients had persistent hypervolemia and required ongoing diuresis despite receiving loop and thiazide diuretics.

  • 3

    STS administration resulted in a decrease in serum total carbon dioxide levels, averaging approximately 5 mmol/L per 25 g dose.

  • 4

    No immediate adverse effects from STS were observed in any of the six patients during the treatment.

  • 5

    The study highlights the limitations of standard treatments for metabolic alkalosis in patients with impaired renal function.

Original Source(s)

Sodium Thiosulfate for Refractory Metabolic Alkalosis From Diuretic Therapy: A Case Series of Six Patients

  • September 1, 2026

Related Content

Predictive value of the serum sodium to log(D-dimer) ratio for the risk of all-cause death in patients with chronic heart failure with different ejection fractions

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

Early in-hospital initiation of angiotensin-receptor–neprilysin inhibitor in post-acute myocardial infarction patients with impaired left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials